VENUS MEDTECH-B(02500),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02500 VENUS MEDTECH-B

Trading 06-09 10:12:59

1.190

+0.020

+1.71%

High1.220	Low1.130	Vol1.17M
Open1.170	D1 Closing1.170	Amplitude7.69%
Mkt Cap524.80M	Tradable Cap524.80M	Total Shares441.01M
T/O1.41M	T/O Rate0.27%	Tradable Shares441.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02500","market":"HK","secType":"STK","nameCN":"VENUS MEDTECH-B","latestPrice":1.19,"timestamp":1780970830126,"preClose":1.17,"halted":0,"volume":1170000,"delay":0,"changeRate":0.01709401709401711,"floatShares":441010235,"shares":441011443,"eps":-0.93,"marketStatus":"Trading","change":0.02,"latestTime":"06-09 10:12:59","open":1.17,"high":1.22,"low":1.13,"amount":1409850,"amplitude":0.076923,"askPrice":1.19,"askSize":32500,"bidPrice":1.15,"bidSize":47500,"shortable":0,"etf":0,"ttmEps":-1.036052,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1780977600000},"marketStatusCode":2,"adr":0,"listingDate":1575907200000,"exchange":"SEHK","adjPreClose":1.17,"openAndCloseTimeList":[[1780968600000,1780977600000],[1780981200000,1780992000000]],"volumeRatio":9.515759,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02500","defaultTab":"news","newsList":[{"id":"2640972001","title":"Venus MedTech Hangzhou announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640972001","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640972001?lang=en_us&edition=fundamental","pubTime":"2026-06-03 16:36","pubTimestamp":1780475775,"startTime":"0","endTime":"0","summary":"Venus MedTech Hangzhou will hold its 2025 annual general meeting in Hangzhou, China on June 25, 2026.Shareholders will vote on the 2025 annual report, the board’s 2025 work report, the supervisory committee’s 2025 work report.Other items include the 2025 profit distribution plan, reappointment of auditors for 2026, general mandates to issue shares or repurchase H shares.The meeting will also review the independent directors’ 2025 work report.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Venus MedTech HangZhou Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 03, 2026, and is solely responsible for the information contained","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL6YBG7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02500","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638969265","title":"Venus Medtech hosts inaugural Global Partner Summit in Paris","url":"https://stock-news.laohu8.com/highlight/detail?id=2638969265","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638969265?lang=en_us&edition=fundamental","pubTime":"2026-05-26 15:00","pubTimestamp":1779778841,"startTime":"0","endTime":"0","summary":"Venus Medtech hosted its inaugural Global Partner Summit in Paris on May 26, 2026.Management laid out an international expansion plan, highlighting commercialization priorities following Venus P-Valve, with Cardiovalve positioned for broader growth.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Venus MedTech HangZhou Inc. published the original content used to generate this news brief via PR Newswire  on May 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL5XrHc2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1574","BK1583","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143820693","title":"HKEX Censures Venus Medtech Former Company Secretary for Oversight in RMB2.48 Billion Director Loans","url":"https://stock-news.laohu8.com/highlight/detail?id=1143820693","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143820693?lang=en_us&edition=fundamental","pubTime":"2026-05-19 17:26","pubTimestamp":1779182809,"startTime":"0","endTime":"0","summary":"Hong Kong Exchanges and Clearing’s subsidiary, The Stock Exchange of Hong Kong Limited (HKEX), has issued a public censure against Mr Wong Wai Chiu, former joint company secretary of Venus Medtech...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165592488","title":"Hong Kong Stock Exchange Disciplines Former Company Secretary of VENUS MEDTECH-B","url":"https://stock-news.laohu8.com/highlight/detail?id=1165592488","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165592488?lang=en_us&edition=fundamental","pubTime":"2026-05-19 17:08","pubTimestamp":1779181726,"startTime":"0","endTime":"0","summary":"The Hong Kong Stock Exchange has issued a statement condemning the former company secretary of VENUS MEDTECH-B (02500), Huang Weichao, and has further instructed him to complete mandatory training....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02500","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635985036","title":"BRIEF-Venus Medtech Hangzhou Says Liqiao Ma Resigns As Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2635985036","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635985036?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:33","pubTimestamp":1778859185,"startTime":"0","endTime":"0","summary":"BRIEF-Venus Medtech Hangzhou Says Liqiao Ma Resigns As Executive DirectorMay 15 (Reuters) - Venus Medtech (Hangzhou) Inc 2500.HK:LIQIAO MA RESIGNS AS EXECUTIVE DIRECTOR EFFECTIVE MAY 15, 2026Further company coverage: 2500.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S130:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","BK1574","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160992116","title":"Venus Medtech: Executive Director Liqiao Ma Resigns Effective 15 May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1160992116","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160992116?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:43","pubTimestamp":1778845408,"startTime":"0","endTime":"0","summary":"Venus Medtech (Hangzhou) Inc. announced that Executive Director Liqiao Ma tendered his resignation, effective 15 May 2026, citing other personal commitments. Upon stepping down, Mr. Ma will not hold...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183227007","title":"Venus Medtech Updates Board and Committee Composition","url":"https://stock-news.laohu8.com/highlight/detail?id=1183227007","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183227007?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:43","pubTimestamp":1778845380,"startTime":"0","endTime":"0","summary":"Venus Medtech (Hangzhou) Inc. announced an updated list of directors and their respective roles across the Board and its committees, effective 15 May 2026. • Board Leadership     – Ting Yuk Anthony...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103291525","title":"VENUS MEDTECH-B Announces Executive Director Ma Liqiao's Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=1103291525","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103291525?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:42","pubTimestamp":1778845357,"startTime":"0","endTime":"0","summary":"VENUS MEDTECH-B (02500) has announced that Mr. Ma Liqiao has tendered his resignation as an executive director, effective from May 15, 2026. The resignation is due to other personal commitments.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1100","BK1583","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635089734","title":"Venus Medtech files list of directors with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2635089734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635089734?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:40","pubTimestamp":1778845247,"startTime":"0","endTime":"0","summary":"Venus Medtech  filed an updated list of directors and board committee roles with Hong Kong Stock Exchange dated May 15, 2026.Board comprises two executive directors, two non-executive directors, three independent non-executive directors.Audit Committee chaired by Chi Wai Suen; members include Ting Yuk Anthony Wu, John Junhua Gu.Remuneration and Assessment Committee chaired by Ting Yuk Anthony Wu; members include Chi Wai Suen, John Junhua Gu.Nomination Committee chaired by John Junhua Gu; members include Meirong Liu, Ting Yuk Anthony Wu, Chi Wai Suen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Venus MedTech HangZhou Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL907DTY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","02500","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635089441","title":"Venus MedTech says executive director Ma Liqiao resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2635089441","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635089441?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:37","pubTimestamp":1778845049,"startTime":"0","endTime":"0","summary":"Venus MedTech HangZhou said executive director Liqiao Ma resigned for personal reasons, effective May 15, 2026.Ma will no longer hold any position within group following resignation.Ma said he had no disagreements with board, no other matters related to resignation were raised.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Venus MedTech HangZhou Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDLc8HqvC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500","BK1100","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635089414","title":"Venus Medtech Hangzhou - Liqiao Ma Resigns as Executive Director Effective May 15, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635089414","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635089414?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:37","pubTimestamp":1778845041,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S130:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02500","BK1583","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635567276","title":"Analysts Expect Venus Medtech (Hangzhou) Inc. (HKG:2500) To Breakeven Soon","url":"https://stock-news.laohu8.com/highlight/detail?id=2635567276","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635567276?lang=en_us&edition=fundamental","pubTime":"2026-05-13 10:35","pubTimestamp":1778639707,"startTime":"0","endTime":"0","summary":"Venus Medtech (Hangzhou) Inc. ( HKG:2500 ) is possibly approaching a major achievement in its business, so we would...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2500/venus-medtech-hangzhou-shares/news/analysts-expect-venus-medtech-hangzhou-inc-hkg2500-to-breake","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2500/venus-medtech-hangzhou-shares/news/analysts-expect-venus-medtech-hangzhou-inc-hkg2500-to-breake","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02500","BK1100","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133294238","title":"VENUS MEDTECH-B Appoints Yip Chui Mui as Company Secretary and Authorized Representative","url":"https://stock-news.laohu8.com/highlight/detail?id=1133294238","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133294238?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:00","pubTimestamp":1778061627,"startTime":"0","endTime":"0","summary":"VENUS MEDTECH-B (02500) has announced that Mr. Wong Wai Chiu has resigned from his positions as the company's secretary and authorized representative. Ms. Yip Chui Mui has been appointed as the new company secretary and authorized representative, effective May 6, 2026.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","02500","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633673185","title":"Venus Medtech names Yip Chui Mei company secretary, authorized representative","url":"https://stock-news.laohu8.com/highlight/detail?id=2633673185","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633673185?lang=en_us&edition=fundamental","pubTime":"2026-05-06 17:56","pubTimestamp":1778061362,"startTime":"0","endTime":"0","summary":"Venus Medtech  named Ms. Yip Chui Mei company secretary, effective May 6, 2026.Yip also took over as authorized representative for Hong Kong matters on the same date.She is an assistant manager at SWCS Corporate Services Group  with more than 10 years of company secretarial experience.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Venus MedTech HangZhou Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL71WTbD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","02500","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136354672","title":"维昇心律2025年营收降至3.07亿元，净亏损同比收窄42.9%，聚焦结构性心脏病全球突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1136354672","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136354672?lang=en_us&edition=fundamental","pubTime":"2026-04-29 16:49","pubTimestamp":1777452560,"startTime":"0","endTime":"0","summary":"据维昇心律（杭州）股份有限公司（「维昇心律」，下称「公司」）2025年度报告显示，期内公司实现营业收入人民币3.07亿元（2024年为4.71亿元），同比下降约34.8%；年内归属于母公司的亏损为人民币4.08亿元，较上年同期约7.14亿元的亏损减少42.9%。非国际财务报告准则（Non-IFRS）口径下，公司2025年EBITDA亏损为2.90亿元，同比下降53.4%。全年销售、管理及研发等费用...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇心律2025年营收降至3.07亿元，净亏损同比收窄42.9%，聚焦结构性心脏病全球突破","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631560187","title":"Venus MedTech Hangzhou publishes 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631560187","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631560187?lang=en_us&edition=fundamental","pubTime":"2026-04-29 16:41","pubTimestamp":1777452094,"startTime":"0","endTime":"0","summary":"Venus Medtech released its 2025 ESG report, keeping reporting scope focused on major China operations with environmental KPIs centered on Hangzhou headquarters.Board oversight remained core to ESG governance, supported by management team execution through an ESG working group.Materiality review identified 21 ESG issues, including 7 rated highly material.Group reported no judicial proceedings tied to corruption, fraud, or money laundering during reporting period.Customer complaint intake totaled 19 cases, with all complaints resolved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Venus MedTech HangZhou Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL2Dr20S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02500","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170801892","title":"Venus Medtech: No Share Capital Changes in March 2026, Public Float Fully Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1170801892","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170801892?lang=en_us&edition=fundamental","pubTime":"2026-04-08 16:41","pubTimestamp":1775637694,"startTime":"0","endTime":"0","summary":"Venus Medtech (Hangzhou) Inc. (Venus Medtech) filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, confirming that both authorised and issued share capital remained...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624155537","title":"Venus MedTech FY25 net loss narrows 43.2% to RMB 410 million; revenue falls 34.8% to RMB 310 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624155537","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624155537?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:31","pubTimestamp":1774992662,"startTime":"0","endTime":"0","summary":"Venus Medtech posted a net loss attributable to owners of RMB 408 million, narrowing 42.9%, with loss per share at RMB 0.93.Revenue fell 34.8% to RMB 307 million, due to lower unit prices and sales volumes amid fiercer competition in China.Adjusted non-IFRS EBITDA was RMB 250 million, little changed with a 1.3% improvement.Overseas revenue rose 19.2% to RMB 98.3 million, while cash and cash equivalents declined 46.9% to RMB 158 million.Pipeline updates included full enrollment of 150 patients for Cardiovalve’s EU pivotal trial with CE MDR submission, while VenusP-Valve’s U.S. IDE pivotal study stayed on track.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Venus MedTech HangZhou Inc. published the original content used to generate this","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL13PGY6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02500","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623435533","title":"BRIEF-Venus Medtech Hangzhou Logs FY Revenue RMB 306.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2623435533","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623435533?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:26","pubTimestamp":1774970776,"startTime":"0","endTime":"0","summary":"BRIEF-Venus Medtech Hangzhou Logs FY Revenue RMB 306.8 MlnMarch 31 (Reuters) - Venus Medtech Hangzhou Inc 2500.HK:FY REVENUE RMB 306.8 MILLIONFY LOSS ATTRIBUTABLE RMB407.7 MILLIONFurther company coverage: 2500.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nPLX697C11:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1100","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114180367","title":"Venus Medtech posts FY2025 loss reduction despite 34.8% revenue decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1114180367","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114180367?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:44","pubTimestamp":1774961092,"startTime":"0","endTime":"0","summary":"Venus Medtech (Hangzhou) Inc. released its audited results for the year ended 31 December 2025, showing mixed performance as the structural-heart device maker navigated an increasingly competitive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.venusmedtech.com","stockEarnings":[{"period":"1week","weight":-0.1136},{"period":"1month","weight":-0.3314},{"period":"3month","weight":-0.5145},{"period":"6month","weight":-0.5125},{"period":"1year","weight":-0.4913},{"period":"ytd","weight":-0.5084}],"compareEarnings":[{"period":"1week","weight":-0.0292},{"period":"1month","weight":-0.0658},{"period":"3month","weight":-0.0502},{"period":"6month","weight":-0.0346},{"period":"1year","weight":0.0363},{"period":"ytd","weight":-0.038}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Venus Medtech Hangzhou Inc is a China-based company principally engaged in the research and development, and the manufacture and sale of bioprosthetic heart valves. The Company mainly engages in minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The Company provides interventional heart valve devices for valvular heart disease including aortic valve, pulmonic valve, mitral valve and tricuspid valve, a radio frequency ablation system for interventional treatment of HCM, a renal artery denervation ultrasound ablation system for interventional treatment of hypertension and other accessory consumables. The Company's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8/TAV8 and TriGUARD3 Cerebral Embolic Protection Device. The Company mainly conducts its businesses in the domestic market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.070986},{"month":2,"riseRate":0.2,"avgChangeRate":-0.071618},{"month":3,"riseRate":0,"avgChangeRate":-0.254926},{"month":4,"riseRate":0.666667,"avgChangeRate":0.054263},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.128903},{"month":6,"riseRate":0.5,"avgChangeRate":0.089922},{"month":7,"riseRate":0.4,"avgChangeRate":0.007533},{"month":8,"riseRate":0.2,"avgChangeRate":-0.115597},{"month":9,"riseRate":0.4,"avgChangeRate":-0.03911},{"month":10,"riseRate":0.2,"avgChangeRate":-0.074139},{"month":11,"riseRate":0.6,"avgChangeRate":0.100743},{"month":12,"riseRate":0.5,"avgChangeRate":-0.006043}],"exchange":"SEHK","name":"VENUS MEDTECH-B","nameEN":"VENUS MEDTECH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VENUS MEDTECH-B(02500),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest VENUS MEDTECH-B(02500) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"VENUS MEDTECH-B,02500,VENUS MEDTECH-B股票,VENUS MEDTECH-B股票老虎,VENUS MEDTECH-B股票老虎国际,VENUS MEDTECH-B行情,VENUS MEDTECH-B股票行情,VENUS MEDTECH-B股价,VENUS MEDTECH-B股市,VENUS MEDTECH-B股票价格,VENUS MEDTECH-B股票交易,VENUS MEDTECH-B股票购买,VENUS MEDTECH-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VENUS MEDTECH-B(02500),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest VENUS MEDTECH-B(02500) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}